L1 Capital’s Boston Scientific BSX Stock Holding History

L1 Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,200	Closed	-$129K	–	22
2025 Q2	$129K	Buy	+1,200	New	+$121K	0.01%	27

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

L1 Capital's BSX Position: Q3 2025 in Review

L1 Capital sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 1,200 shares — an estimated $129K sold.

L1 Capital first reported a position in BSX in Q2 2025 and held it in 1 quarter. The position peaked at $129K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

L1 Capital reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
L1 Capital sold 1,200 Boston Scientific shares in Q3 2025, an estimated $129K.
L1 Capital first reported a position in Boston Scientific in Q2 2025 and held it in 1 quarter.
L1 Capital's Boston Scientific position peaked at $129K in Q2 2025.
1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on L1 Capital's 13F filing for Q3 2025, filed 14 Nov 2025.